𝔖 Bobbio Scriptorium
✦   LIBER   ✦

171. Clinical and pharmacologic aspects of all-trans retinoic acid treatment in acute promyelocytic leukemia

✍ Scribed by Warrell, RP; Frankel, S; Miller, WH; Muindi, J; Young, C; Dmitrovsky, E

Book ID
122431560
Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
138 KB
Volume
46
Category
Article
ISSN
0753-3322

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pharmacology of all-trans-retinoic acid
Pharmacology of all-trans-retinoic acid in children with acute promyelocytic leukemia
✍ Lanvers, Claudia ;Reinhardt, Dirk ;DΓΌbbers, Angelika ;Wagner-Bohn, Alexandra ;Cr πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 158 KB πŸ‘ 1 views

## Abstract ## Background Due to severe side effects in virtually all children treated with a standard dose of 45 mg/m^2^/day all‐__trans__‐retinoic acid (ATRA) for acute promyelocytic leukemia (APL) the AML‐BFM study group reduced the dosage to 25 mg/m^2^/day. For the lack of data on the use of A

ALL-TRANS RETINOIC ACID (ATRA) IN THE TR
ALL-TRANS RETINOIC ACID (ATRA) IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL)
✍ C. S. CHIM; Y. L. KWONG; R. LIANG; Y. C. CHU; C. H. CHAN; L. C. CHAN; K. F. WONG πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 498 KB πŸ‘ 2 views

Acute promyelocytic leukemia is characterized by the reciprocal translocation of chromosomes 15 and 17. All-trans retinoic acid (ATRA) efficiently induces differentiation of the abnormal promyelocytes. In this study, we had used ATRA as the primary induction therapy for 17 newly diagnosed patients,